291WC, Director, Pharmacovigilance (PVG) Operations

Job Code 291WC


We are seeking a hands-on pharmacovigilance professional to lead and direct PVG safety risk management operations for Fate Therapeutics sponsored clinical trials of engineered immune cell therapy for the treatment of cancer. This position oversees adverse event report collection and processing at participating clinical trial sites, manages PVG training and compliance, and leads the collection and reporting of individual case safety reports (ICSR) and other defined safety data across all clinical development programs. The position provides strategic leadership and guidance to PVG staff and establishes and maintains relationships with CROs and vendors supporting PVG operations deliverables. This position collaborates cross-functionally with clinical development, clinical operations, regulatory affairs, and quality assurance teams. This position will initially report to the VP, Clinical Development, and is based at the Company’s corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 291WC.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.